Lannett Petitions for Stay of Glycolax Withdrawal Order By Sam | April 13, 2018 Lannett filed an emergency petition with the FDA requesting postponement of the agency’s withdrawal order for its ANDA for Glycolax pending a court ruling. Source: Drug Industry Daily Posted in Drug Industry Daily